Code No. | 554 | |
Anti-p27Kip1 pAb | ||
Size | 100 µL | |
Availability (in Japan) | 1-9
(In Japan at 17:33, Apr 26, 2024 in JST) |
|
Clonality | Polyclonal | |
Clone | Polyclonal | |
Isotype (Immunized Animal) |
Rabbit Ig (aff.) | |
Applications | WB 1:100-1:1,000 IP 5 μL/100 μL of cell extract from 5x106 cells FCM 1:100 (final concentration) IC 1:100 |
|
Immunogen (Antigen) |
Recombinant Mouse p27kip1 | |
Reactivity [Gene ID] | ||
Storage buffer | PBS/50% glycerol, pH 7.2 | |
Storage temp. | -20°C | |
Conjugate | Unlabeled | |
Manufacturer | MBL | |
Alternative names | CDKN1B | |
Background | Cyclin dependent kinase inhibitory protein 1 (Kip1) is a 27 kDa inducible inhibitor of cyclin-dependent kinase complexes (CKI). It acts by suppressing S-phase entry and thereby blocking cell cycle progression. Kip1 interacts strongly with D-type cyclins in complex with Cdk4 and weaklier with cyclin E/Cdk2 complex to cause G1 arrest. Kip1 is a potent tumor suppressor for multiple epithelially derived neoplasias, and expression of Kip1 is frequently down regulated in human tumors. Kip1 levels are regulated by phosphorylation and degradation via the ubiquitin-proteosome pathway. | |
Product category | Research area:Cancer | |
Data |